Helus Pharma Inc. (HELP) stock
HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
$8.86−0.53 (-5.64%)
Close on Nov 12, 2026Market cap $457.46MP/E –Yield –
Helus Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Helus Pharma's enterprise value was $326.80M on Nov 11, 2026, against $28.35M a year earlier. Over the last 5 years it ranged from -$95.61M to $427.73M, with a median of $41.96M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $326.80M | +388.1% |
| 2025 | Dec 31, 2025 | $66.95M | – |
| 2024 | Dec 31, 2024 | -$71.95M | -213.4% |
| 2023 | Dec 29, 2023 | $63.43M | +531.5% |
| 2022 | Dec 30, 2022 | $10.04M | -85.6% |
| 2021 | Dec 31, 2021 | $69.90M | – |
See a number that looks wrong?